Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT05134922

Available

Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009

Breast Neoplasm Malignant Female
NCT05739175

Completed

The Effect of the Mobile Application-based Support Program on the Outcomes of Breast Cancer Patients in the Pandemic

Breast Cancer | Nursing
NCT04289805

Terminated

Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE) (fAMHOPE)

Breast Neoplasm Malignant Female
NCT06382441

Completed

A Tele-exercise Program for Breast Cancer Survivors

Behavior, Health
NCT05192525

Completed

The Effects of a Nurse-led MHealth Program for Symptom Self-management of Breast Cancer Patients Undergoing Chemotherapy (mChemo)

Breast Cancer | Chemotherapeutic Toxicity
NCT04088877

Completed

Rise Up After Breast Cancer (RISE-UP)

Breast Cancer | Body Image
NCT05901142

Active, not recruiting

Prehabilitation and RecOVERy From Surgery for Breast Cancer Study (PROVERB)

Exercise | Breast Neoplasm Female
NCT03425656

Completed

Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer

Malignant Neoplasm of Breast
NCT01996267

Active, not recruiting

Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 (TRAIN-2)

Breast Cancer | HER2 Positive
NCT03280836

Completed

Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy (WISER-NET)

Physical Activity | Breast Neoplasm
NCT06134570

Enrolling by invitation

ALDH1A1 Expression in Invasive Mammary Carcinoma

Breast Cancer
NCT04562233

Terminated

Breast Cancer and Resistance Exercise Program (B-REP)

Breast Cancer | Resistance Training
NCT05159778

Completed

Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)

Malignant Neoplasm of Breast
NCT05128617

Completed

Acute Effects of Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: the PROTECT-06 Study (PROTECT-06)

Breast Cancer
NCT03860740

Completed

Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients (EFIK)

Breast Cancer | Luminal B
NCT00976131

Completed

Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer

Breast Cancer
NCT02720185

Terminated

Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR

Breast Neoplasms | Triple Negative Breast Neoplasms
NCT01702571

Completed

A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment

Breast Cancer
NCT02763228

Completed

Physical Activity Intervention to Reduce Functional Health Disparities Among Breast Cancer Survivors

Breast Cancer | Physical Activity
NCT02595372

Completed

Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy

Cancer of the Breast
NCT00464646

Completed

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

Breast Cancer
NCT03908528

Completed

Alpha-Lipoic Acid in Breast Cancer Patients

Breast Cancer | Chemotherapeutic Toxicity
NCT04882371

Completed

Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer

Breast Cancer | Chemotherapy Effect
NCT03289819

Completed

Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC (NIB)

Malignant Neoplasm of Breast
NCT00397761

Withdrawn

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Breast Cancer
NCT03702868

Terminated

Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast Cancer

Breast Cancer | Adjuvant Chemotherapy
NCT03429101

Terminated

A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer

Breast Cancer
NCT04669522

Unknown

Psychological Factors and Oncological Outcomes of Triple-negative Breast Cancer (PSY-ONC TNBC)

Triple Negative Breast Neoplasms
NCT02165605

Completed

HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer

Breast Cancer
NCT00193778

Completed

Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation

Cancer of the Breast
NCT04418089

Completed

Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer

Breast Cancer | Chemotherapy Effect
NCT00524277

Completed

Vaccine Therapy in Treating Patients With Breast Cancer

Breast Cancer
NCT04202328

Unknown

T-DM1 in HER2-positive Metastatic/Relapsed Breast Cancer

Breast Cancer
NCT01799031

Completed

Educational Intervention for Reducing Work Disability in Breast Cancer Survivors

Breast Cancer | Cancer Survivor
NCT01328249

Completed

Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer

HER2-normal
NCT02683083

Completed

Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients (CAM-VHH1)

Breast Cancer | Healthy Volunteers
NCT03954197

Unknown

Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients (PRIMIV)

Breast Cancer | Fertility Preservation
NCT01953003

Completed

Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Malignant Neoplasm of Breast
NCT00847171

Completed

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

Breast Cancer
NCT02495363

Completed

Analgesic Effects of Ultrasound Guided PEC Blocks on Analgesic Opioid Consumption of Cancer Surgery Patients

Malignant Neoplasm of Breast
NCT03596463

Unknown

Influence of Multidisciplinary Breast Tumor Board on Physician Decision

Breast Cancer | Breast Neoplasms | Surgery | Oncology
NCT03471741

Completed

Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer

Breast Cancer | Radiation Toxicity
NCT03461224

Completed

Modulated Accelerated RAdiotherapy in Early Breast Cancer

Breast Cancer | Radiation Toxicity
NCT02769104

Unknown

Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer (ACCN)

Neoadjuvant Therapy
NCT00723294

Unknown

Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer

Breast Cancer
NCT02964286

Unknown

The Effect of Acupoint Massotherapy on Relieving Chemotherapy-induced Myelosupression

Cancer, Breast | Acupressure | Hematopoiesis
NCT01660542

Completed

An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer

Locally Advanced Breast Cancer
NCT00829166

Completed

A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer (EMILIA)

Breast Cancer
NCT02539017

Withdrawn

The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer

Triple Negative Breast Neoplasms
NCT00450892

Completed

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations